Zinc Supplementation and Severe and Recurrent Diarrhea

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-01-31

Study Completion Date

2010-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluating the impact of 3 months daily zinc supplementation on incidence of severe and recurrent diarrhea in 6 to 36 months age children in Bandarabbaas

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Impact of Zinc and Probiotics in Preventing Pediatric Antibiotic-Associated Diarrhea in Southern Iran

NCT06665503

Antibiotic-associated Diarrhea Diarrhea

COMPLETED NA

Zinc Dosing Trial - Does Dose Reduction Reduce Side Effects But Retain Efficacy in Diarrhoea Management

NCT03078842

Diarrhea

COMPLETED NA

Efficacy of Zinc Therapy in Acute Diarrhoea in Young Children

NCT00325247

Acute Watery Diarrhoea

COMPLETED PHASE3

Daily Zinc Supplement Effect on Prevention of Diarrhea and Acute Respiratory Infections in Children Less Than Five Years

NCT05002101

Zinc Deficiency Child Nutrition Disorders

COMPLETED PHASE4

Comparing the Efficacy of Different Zinc Formulations in the Treatment of Diarrhea

NCT00682955

Incidence of Acute Diarrhea Incidence of Abdominal Pain

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Evaluating the impact of 3 months daily zinc supplementation on incidence of severe and recurrent diarrhea in 6 to 36 months age children in Bandarabbaas in 2009

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diarrhea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Zinc sulfate

daily zinc supplementation for 3 months. (10mg daily for under 1 years old children and 20mg daily for above 1 years old children)

Group Type EXPERIMENTAL

Zinc Supplement

Intervention Type DRUG

10mg daily for under 1 years old children and 20mg daily for above 1 years old children

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Zinc Supplement

10mg daily for under 1 years old children and 20mg daily for above 1 years old children

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Zinc sulfate Oral Zinc

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All 6 to 36 months old children without diarrhea at the time of study and without disease such as celiac
* Inflammatory bowl disease and hypersensitivity to milk